NYSE: BWXTBwx Technologies Inc Stock
$126.01-1.96 (-1.53%)
Updated Dec 6, 2024
BWXT Price
$126.01
Fair Value Price
N/A
Market Cap
$11.52B
52 Week Low
$74.69
52 Week High
$136.31
P/E
41.59x
P/B
10.88x
P/S
3.71x
PEG
5.76x
Dividend Yield
0.76%
Revenue
$2.68B
Earnings
$276.81M
Gross Margin
24.9%
Operating Margin
14.82%
Profit Margin
10.3%
Debt to Equity
1.78
Operating Cash Flow
$353M
Beta
0.66
Next Earnings
N/A
Ex-Dividend
Nov 19, 2024
Next Dividend
Dec 10, 2024
BWXT Overview
BWX Technologies, Inc. designs and enginees naval nuclear components, reactors, and nuclear fuel for the U.S. government. BWX also provides uranium processing, environmental site restoration services, and other solutions to the nuclear power industry. Known as Babcock & Wilcox Company until 2015, the company was founded in 1867 and is headquartered in Lynchburg, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BWXT's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
C
Momentum
B
Sentiment
B
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important BWXT news, forecast changes, insider trades & much more!
BWXT News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BWXT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BWXT ($126.01) is trading above its intrinsic value of $24.80, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BWXT is poor value based on its earnings relative to its share price (41.59x), compared to the US market average (29.86x)
P/E vs Market Valuation
BWXT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more BWXT due diligence checks available for Premium users.
Valuation
BWXT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
41.59x
Industry
35.87x
Market
29.86x
BWXT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BWXT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
BWXT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
10.88x
Industry
6.4x
BWXT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BWXT price to earnings growth (PEG)
For valuing profitable companies with growth potential
BWXT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
BWXT's financial health
Profit margin
Revenue
$672.0M
Net Income
$69.5M
Profit Margin
10.3%
BWXT's Earnings (EBIT) of $397.56M... subscribe to Premium to read more.
Interest Coverage Financials
BWXT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.9B
Liabilities
$1.9B
Debt to equity
1.78
BWXT's short-term assets ($982.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BWXT's long-term liabilities ($1.45B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BWXT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BWXT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$32.6M
Investing
-$40.3M
Financing
-$4.9M
BWXT's operating cash flow ($353.31M)... subscribe to Premium to read more.
Debt Coverage Financials
BWXT vs Defense Stocks
Bwx Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.